Hims & Hers Health (NYSE: HIMS) discloses director RSU vesting

Rhea-AI Filing Summary

Hims & Hers Health, Inc. reported an insider equity transaction by director and Chief Policy Officer Deborah M Autor. On December 15, 2025, 7,054 restricted stock units (RSUs) were converted into the same number of Class A common shares, increasing her directly held stake to 13,229 shares.

The RSUs carry a service-based vesting schedule over three years. One third vests on December 15, 2025, another third on December 15, 2026, and the final third on December 15, 2027. After this transaction, Autor continues to hold 14,110 RSUs, each representing the right to receive one Class A common share at no cash exercise price.

Insider Trade Summary

7,054 shares exercised/converted

Mixed 2 txns

Insider Autor Deborah M.

Role Chief Policy Officer

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit	7,054	$0.00	--
Exercise	Class A Common Stock	7,054	$0.00	--

Holdings After Transaction: Restricted Stock Unit — 14,110 shares (Direct); Class A Common Stock — 13,229 shares (Direct)

Footnotes (1)

1. The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 3-year period, with (i) 1/3 of the RSUs vesting on December 15, 2025, (ii) 1/3 of the RSUs vesting on December 15, 2026, and (iii) 1/3 of the RSUs vesting on December 15, 2027.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Autor Deborah M.

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CA 94123

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Policy Officer

3. Date of Earliest Transaction (Month/Day/Year)
12/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	12/15/2025		M		7,054	A	(1)	13,229	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	12/15/2025		M			7,054	(2)	(2)	Class A Common Stock	7,054	$0	14,110	D

Explanation of Responses:

1. The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

2. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 3-year period, with (i) 1/3 of the RSUs vesting on December 15, 2025, (ii) 1/3 of the RSUs vesting on December 15, 2026, and (iii) 1/3 of the RSUs vesting on December 15, 2027.

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for Deborah M Autor	12/16/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did HIMS report for Deborah M Autor on December 15, 2025?

Deborah M Autor reported the conversion of 7,054 restricted stock units (RSUs) into 7,054 shares of Hims & Hers Health Class A common stock on December 15, 2025, coded as transaction type M.

How many HIMS Class A shares does Deborah M Autor own after this transaction?

Following the reported transaction, Deborah M Autor beneficially owns 13,229 shares of Hims & Hers Health Class A common stock in direct ownership.

What is the vesting schedule for Deborah M Autor’s RSUs at HIMS?

The RSUs vest over a 3-year period: 1/3 vests on December 15, 2025, another 1/3 on December 15, 2026, and the final 1/3 on December 15, 2027, subject to service-based vesting conditions.

How many HIMS restricted stock units does Deborah M Autor hold after the reported transaction?

After the December 15, 2025 transaction, Deborah M Autor holds 14,110 restricted stock units (RSUs), each representing a contingent right to receive one share of Class A common stock.

What roles does Deborah M Autor hold at Hims & Hers Health (HIMS)?

Deborah M Autor is reported as both a Director and an Officer, serving as the company’s Chief Policy Officer.

What is the exercise price of Deborah M Autor’s RSUs at HIMS?

The reported restricted stock units convert into Class A common stock at an exercise price of $0, meaning no cash payment is required upon settlement.